Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hyun-Kwang Tan"'
Autor:
Joo Han Lee, Soo Heui Paik, Ji Han Kim, Sang Lin Kim, Howard Lee, Yong Ha Chi, Hyun Kwang Tan, Byoung Wook Yoo
Publikováno v:
American Journal Cardiovascular Drugs. 11:335-346
Fimasartan (BR-A-657) is a novel, non-peptide angiotensin II receptor antagonist with a selective type I receptor blockade effect. Two first-in-human studies investigated the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of f
Autor:
Yohan Choi, Tae Hwan Kim, Beom Soo Shin, Hyun Kwang Tan, Soo Heui Paik, Yong Ha Chi, Sun Dong Yoo, Minki Kim, Joo Han Lee
Publikováno v:
Biomedical Chromatography. 25:1208-1214
Fimasartan, 2-butyl-5-dimethylaminothiocarbonylmethyl-6-methyl-3-[[2'-(1H tetrazol -5-yl)biphenyl-4-yl]methyl]pyrimidin-4(3H)-one (BR-A-657), is a novel angiotensin II receptor blocker exhibiting potent and selective AT1 receptor blocking activity. T
Autor:
Song-Jae Lee, Tae-Ho Kwon, Moon-Sik Yang, Mi-Young Park, Cheon-Ik Park, Wuk-Sang Ryu, Sang-Min Lim, Hyun-Kwang Tan, Hahn-Sun Jung, Dong-Il Kim
Publikováno v:
Protein Expression and Purification. 51:293-302
Human cytotoxic T-lymphocyte antigen 4-immunoglobulin (hCTLA4Ig) fusion protein, a novel immunosuppressive agent, was expressed in transgenic rice cell suspension culture and its characteristics and in vitro activities were investigated. The expressi
Autor:
Song-Jae Lee, Ju-Yeop Shin, Cheon-Ik Park, Dong-Il Kim, Hahn-Sun Jung, Hyun Kwang Tan, Jae-Kyung Koo, Sang Min Lim, Myung-Hwan Kim
Publikováno v:
Biotechnology Letters. 28:2039-2048
The avidity for CD80Ig/CD86Ig and the in vitro immunosuppressive effect of recombinant human cytotoxic T lymphocyte-associated antigen 4-immunoglobulin, produced by transgenic rice cell suspension cultures (hCTLA4Ig(P)) with CHO-derived recombinant h
Autor:
Joo Han Lee, Hong-Kun Rim, Jae Yeol Lee, Hyun Kwang Tan, Je Hak Kim, Soo Heui Paik, Kyung-Tae Lee, Yong Ha Chi, Sang Lin Kim
Publikováno v:
Biologicalpharmaceutical bulletin. 36(7)
The pharmacological profile of BR-A-657, 2-n-butyl-5-dimethylamino-thiocarbonyl-methyl-6-methyl-3-{[2-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-pyrimidin-4(3H)-one, a new nonpeptide AT1-selective angiotensin receptor antagonist, has been investigated
Autor:
Beom Soo, Shin, Tae Hwan, Kim, Soo Heui, Paik, Yong Ha, Chi, Joo Han, Lee, Hyun Kwang, Tan, Yohan, Choi, Minki, Kim, Sun Dong, Yoo
Publikováno v:
Biomedical chromatography : BMC. 25(11)
Fimasartan, 2-butyl-5-dimethylaminothiocarbonylmethyl-6-methyl-3-[[2'-(1H tetrazol -5-yl)biphenyl-4-yl]methyl]pyrimidin-4(3H)-one (BR-A-657), is a novel angiotensin II receptor blocker exhibiting potent and selective AT1 receptor blocking activity. T
Autor:
Sang-Min Lim, Song-Jae Lee, Hyun-Kwang Tan, Jin J. Lim, Chan-Hi Joung, Ju-Yeop Shin, Jin-Sang Wang, Sang-Lin Kim, Jae-Kyung Koo
Publikováno v:
Protein expression and purification. 68(2)
A long-lasting recombinant human albumin-linker-erythropoietin (EPO) is a human albumin gene fused to the N-terminal of EPO with a (GGSGG)(n)-repeated linker inserted between albumin and EPO. Albumin-EPO fusion genes were co-transfected with the dhfr
Autor:
Sang-Min, Lim, Hahn-Sun, Jung, Min Ja, Kim, Dae-Won, Park, Woo-Joo, Kim, Hee-Jin, Cheong, Seung-Chul, Park, Kwang-Chul, Lee, Young-Kyoo, Shin, Hyun Kwang, Tan, Sang-Lin, Kim, Jang Wook, Sohn
Publikováno v:
Journal of microbiology and biotechnology. 17(4)
The purpose of this study was to evaluate the immunogenicity and safety of Salmonella Typhi Vi capsular polysaccharide vaccine (Vi vaccine) in Korea. The immunogenicity of a single dose of Vi vaccine was evaluated in 157 subjects (75 children and 82
Autor:
Yong Ha Chi, Howard Lee, Soo Heui Paik, Joo Han Lee, Byoung Wook Yoo, Ji Han Kim, Hyun Kwang Tan, Sang Lin Kim
Publikováno v:
American Journal of Cardiovascular Drugs; 2011, Vol. 11 Issue 5, p335-346, 12p, 2 Charts, 6 Graphs